Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

T cells are white blood cells that are important for adaptive immunity. They have unique cell surface receptors that are generated by randomly assorting genes. These receptors allow T cells to ...

The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard ...

Rahul Banerjee, MD, FACP, assistant professor in the Division of Hematology and Oncology, University of Washington, dissects the limited data on T-cell therapies for multiple myeloma, infectious ...

These cells deal with microbes and repair tissue damage. Two main sub-types of immune cells are T cells and macrophages. T cells are designed to recognise the molecular signatures of particular ...

Mayo Clinic researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in some patients.

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective.

Helene continues to unleash its fury across the Southeast after leaving at least 49 people dead in multiple states, leveling ...

A 45-year-old woman was evaluated in the rheumatology clinic because of possible IgG4-related disease. She had polyclonal ...

The findings were promising, potentially creating a path to similarly grown proteins such as milk alternatives, artificial ...

Research showed that this prohibition is in place to prevent cell phones from potentially interfering ... so users can access their phone but it doesn't produce a signal. In the U.S., the Federal ...

After crashing 24% in August, Plug Power (NASDAQ: PLUG) stock is going ballistic and just clocked some solid weekly gains -- ...